KTTA Pasithea Therapeutics Corp.
Healthcare$0.68-2.82%ClosedMarket Cap: $5.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.00
P/S
0.00
EV/EBITDA
2355.43
DCF Value
$7.85
FCF Yield
-325.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-0.1%
ROA
-0.0%
ROIC
-0.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-4.9M | $-2.9M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-10.3M | $-10.1M | $— | — |
| FY null | $0.00 | NaN% | $-20.9M | $-20.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.1M | $-3.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-3.8M | $-3.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-3.7M | $-3.6M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-3.3M | $-3.2M | $— | — |
| FY null | $0.00 | NaN% | $-14.2M | $-13.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.0M | $-3.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-3.9M | $-3.9M | $— | — |
| Q1 null | $0.00 | NaN% | $-4.0M | $-3.9M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-5.1M | $-5.0M | $-4.85 | — |